CeNTI -

DOSEA project aims to develop a smart label to support drug therapy. This solution is a highly attractive product at pharmaceutical and hospital level, not only for clinical trials but also for home users. This project aims to develop a discreet and intuitive monitoring device which can be easily integrated into different types of medication packaging, including low-cost blister packs or medicine bottles of liquids/powders.

During DOSEA project, the consortium aims to create three products with a high degree of innovation, which allows the patient to monitor the adherence to medication, thus contributing to the mitigation of a global problem and leveraging the regional and national economy.

DOSEA is being developed in partnership with a European project “Sensing Robotics for Smarter Biotechnology – SR4SB”. This project was submitted to the EURIPIDES2 Program, which received approval with the EURIPIDES label.